Inventor
DE CLERCQ ERIK
BE20 patents
⚠️ This page may combine multiple inventors who share the name “DE CLERCQ ERIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LEUVEN K U RES & DEV
6 patentsUS8008470B2Aug 30, 2011
Integrase cofactor
LEUVEN K U RES & DEV9 citations80
US7514233B2Apr 7, 2009
Integrase cofactor
LEUVEN K U RES & DEV11 citations80
US9249177B2Feb 2, 2016
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
LEUVEN K U RES & DEV2 citations61
US8809520B2Aug 19, 2014
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
LEUVEN K U RES & DEV3 citations61
US9522932B2Dec 20, 2016
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
LEUVEN K U RES & DEV0 citations51
US7049332B2May 23, 2006
HIV inhibiting N-aminoimidazole derivatives
LEUVEN K U RES & DEV0 citations28
STICHTING REGA V Z W
4 patentsUS4724233AFeb 9, 1988
Therapeutical application of phosphonylmethoxyalkyl adenines
STICHTING REGA V Z W114 citations95
US4230708AOct 28, 1980
Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
STICHTING REGA V Z W18 citations82
US4988678AJan 29, 1991
Combinations of FU and BVU as anti-adenocarcinoma agents
STICHTING REGA V Z W3 citations57
US4894365AJan 16, 1990
Combinations of FU and BVU as anti-adenocarcinoma agents
STICHTING REGA V Z W4 citations57